Rocket Pharmaceuticals, Inc.

RCKT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001281895

SEC filings (opens in a new tab)

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of RCKT: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Of which not filed for Q2 2021	Q2 2021	Change
Holders	173	1	150	−22
Shares	62.0M	5.20K	61.9M	−92.5K (−0.1%)
Value	$2.75B	$231.0K	$2.74B	−$13.1M (−0.5%)

1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to RCKT in Q2 2021
Institution	Shares	Value	% of portfolio
Cowen and Company, LLC	1,000,000	$44.3M	2.35%
Nordea Investment Management AB	179,683	$7.96M	0.01%
Maverick Capital LtdSuperinvestorMaverick Capital	173,887	$7.70M	0.07%
Blueshift Asset Management, LLC	12,457	$552.0K	0.03%
Tuttle Tactical Management	6,027	$267.0K	0.12%
Marathon Capital Management	5,672	$251.0K	0.06%
Amundi	3,836	$170.0K	0.00%
Heritage Wealth Management, LLC	100	$4.00K	0.00%
Signaturefd, LLC	31	$1.00K	0.00%
TD Private Client Wealth LLC	18	$797	0.00%

Sold out (32)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of RCKT in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Candriam Luxembourg S.C.A.	128,749	$6.78M
Millennium Management LLC	124,560	$5.53M
California Public Employees Retirement System	64,028	$2.84M
EAM Investors, LLC	32,625	$1.45M
Ensign Peak Advisors, Inc	32,021	$1.42M
Susquehanna Fundamental Investments, LLC	25,900	$1.15M
Graticule Asia Macro Advisors LLC	25,000	$1.11M
Duality Advisers, LP	23,589	$1.05M
Migdal Insurance & Financial Holdings Ltd.	20,093	$892.0K
Squarepoint Ops LLC	18,923	$840.0K
SEI Investments Co	12,997	$713.0K
Qube Research & Technologies Ltd	13,650	$606.0K
Fred Alger Management, LLC	12,495	$554.0K
Quantitative Systematic Strategies LLC	10,873	$482.0K
Federated Hermes, Inc.	9,338	$414.0K
First Midwest Bank Trust Division	9,179	$407.0K
Dynamic Technology Lab Private Ltd	9,022	$400.0K
Copernicus Capital Management, LLC	8,000	$355.0K
Athanor Capital, LP	6,819	$303.0K
Trexquant Investment LP	5,681	$252.0K
Bridgefront Capital, LLC	4,810	$213.0K
Premier Asset Management LLC	4,710	$209.0K
Bank of Montreal	3,001	$128.0K
Cutler Group LP	2,900	$128.0K
Rockefeller Capital Management L.P.	2,330	$103.0K
Pacer Advisors, Inc.	1,447	$64.0K
Ikarian Capital, LLC	1,400	$61.0K
Simplex Trading, LLC	1,350	$59.0K
Lindbrook Capital, LLC	236	$10.0K
Tarbox Family Office, Inc.	19	$1.00K
Meridian Wealth Partners, LLC	36	$1.00K
IFP Advisors, Inc	15	$0

Not filed for Q2 2021 yet (1)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q1 2021 that haven't filed for Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Amundi Asset Management US, Inc.	5,200	$231.0K